Standard chemotherapy for myelomatosis: an area of great controversy.

@article{Boccadoro1992StandardCF,
  title={Standard chemotherapy for myelomatosis: an area of great controversy.},
  author={Mario Boccadoro and Alessandro Pileri},
  journal={Hematology/oncology clinics of North America},
  year={1992},
  volume={6 2},
  pages={371-82}
}
L-PAM and prednisone (MP) has been challenged, almost from the start, by combination chemotherapy (CT) with its strong theoretic backing, as the standard chemotherapy for multiple myeloma. In effect, the two contestants were really evenly matched. Unfortunately, neither of them has been able to provide a satisfactory weapon against this remarkably resistant… CONTINUE READING